Office of Orphan Products Development

First Page		Document Content
Food and Drug Administration Pharmacology Drug discovery Epidemiology Nursing research Orphan drug Orphan Drug Act Xyrem Clinical trial Medicine Health Pharmaceutical sciences		Office of Orphan Products Development Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 110,97 KB Share Document on Facebook

	XYREM® (SODIUM OXYBATE) ORAL SOLUTION DocID: Uq1c - View Document
	Statement of Principles concerning NARCOLEPSY No. 58 of 2005 for the purposes of the DocID: TZWH - View Document
	How to Submit a Study to the FDA for an IND Consult DocID: R5Gg - View Document
	Hypersomnia Practice Parameters for the Treatment of Narcolepsy and other Hypersomnias of Central Origin An American Academy of Sleep Medicine Report Timothy I. Morgenthaler, MD1; Vishesh K. Kapur, MD, MPH2; Terry M. Br DocID: Nb3Z - View Document
	Municipal Health Benefit Plan Prescription Drug Program – Prior Authorization List The Municipal Health Benefit Fund prescription drug pro DocID: Mkj7 - View Document